Blog

Giuseppe Minniti: We desperately need a new meningioma classification to better select patients who need adjuvant stereotactic radiosurgery/stereotactic radiation therapy

Photo of Giuseppe Minniti from ao-siena.toscana.it

Aug 13, 2023, 19:09

Giuseppe Minniti: We desperately need a new meningioma classification to better select patients who need adjuvant stereotactic radiosurgery/stereotactic radiation therapy

Quoting Giuseppe Minniti, Chair of the Academic Unit of Radiation Oncology in the Department of Medicine, Surgery, and Neuroscience at the University of Siena:

“We desperately need a new meningioma classification to better select patients who need adjuvant stereotactic radiosurgery/stereotactic radiation therapy. Waiting for EORTC meningioma committee trials and studies and presentations at EANO meeting in Rotterdam 2023.”

Source: Giuseppe Minniti / Twitter

cancer EORTC Giuseppe Minniti meningioma OncoDaily Oncology radiation oncology Rotterdam stereotactic radiation therapy stereotactic radiosurgery University of Siena

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage